Form D · Biotechnology
AGENUS INC
Lexington, MA · CIK 0001098972
Offering snapshot reported Feb 1, 2019 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 23, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2019 | Initial | $30,000,000 | No comparison | 1 | SEC filing |
| Oct 25, 2018 | Initial | $40,000,653 | No comparison | 2 | SEC filing |
| Mar 1, 2017 | Initial | $60,000,000 | No comparison | 1 | SEC filing |
| Jan 8, 2016 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 4, 2016 | Initial | $7,400,090 | No comparison | 17 | SEC filing |
| Sep 23, 2015 | Initial | $2,142,000 | No comparison | 2 | SEC filing |
| Mar 5, 2015 | Initial | $21,140,000 | No comparison | 8 | SEC filing |
| Mar 5, 2015 | Initial | $35,000,000 | No comparison | 1 | SEC filing |
| Apr 25, 2013 | Initial | $5,000,000 | No comparison | 3 | SEC filing |
| Aug 13, 2009 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Aug 13, 2009 | Initial | $10,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-332007
Source: Form D, filed Feb 1, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Garo H. Armen | Director, Executive |
| Charles Evan Ballantyne | Executive |
| Ozer Baysal | Executive |
| Jennifer Buell | Executive |
| Christian Cortis | Executive |
| Brian Corvese | Director |
| Tom Dechaene | Director |
| Alex Duncan | Executive |
| John Hatsopoulos | Director |
| Allison Jeynes Ellis | Director |
| Wadih Jordan | Director |
| Evan Kearns | Executive |
| Christine Klaskin | Executive |
| Hyam I Levitsky, M.D | Director |
| Hyam I Levitsky, M. D. | Director |
| Shahzad Malik | Director |
| Timothy Rothwell | Director |
| Shalini Sharp | Director |
| Robert B. Stein | Executive |
| Karen H. Valentine | Executive |
| Kerry Wentworth | Executive |
| Ulf Wiinberg | Director |
| Timothy R. Wright | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3 Forbes Road
Lexington, MA, 02421
Lexington, MA, 02421